- Home
- PTPI vs SCNI Comparison
PTPI vs SCNI Comparison
Compare PTPI & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTPI
- SCNI
- Stock Information
- Founded
- PTPI 2020
- SCNI 2003
- Country
- PTPI United States
- SCNI Israel
- Employees
- PTPI N/A
- SCNI N/A
- Industry
- PTPI Biotechnology: Pharmaceutical Preparations
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PTPI Health Care
- SCNI Health Care
- Exchange
- PTPI Nasdaq
- SCNI Nasdaq
- Market Cap
- PTPI 3.1M
- SCNI 3.0M
- IPO Year
- PTPI N/A
- SCNI N/A
- Fundamental
- Price
- PTPI $0.27
- SCNI $3.54
- Analyst Decision
- PTPI
- SCNI
- Analyst Count
- PTPI 0
- SCNI 0
- Target Price
- PTPI N/A
- SCNI N/A
- AVG Volume (30 Days)
- PTPI 1.2M
- SCNI 6.9K
- Earning Date
- PTPI 03-31-2025
- SCNI 11-22-2024
- Dividend Yield
- PTPI N/A
- SCNI N/A
- EPS Growth
- PTPI N/A
- SCNI N/A
- EPS
- PTPI N/A
- SCNI 8.20
- Revenue
- PTPI $4,022,389.00
- SCNI $452,000.00
- Revenue This Year
- PTPI N/A
- SCNI N/A
- Revenue Next Year
- PTPI $0.76
- SCNI N/A
- P/E Ratio
- PTPI N/A
- SCNI $0.43
- Revenue Growth
- PTPI N/A
- SCNI N/A
- 52 Week Low
- PTPI $0.22
- SCNI $2.23
- 52 Week High
- PTPI $2.27
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- PTPI 39.88
- SCNI 51.37
- Support Level
- PTPI $0.30
- SCNI $3.45
- Resistance Level
- PTPI $0.30
- SCNI $3.61
- Average True Range (ATR)
- PTPI 0.03
- SCNI 0.12
- MACD
- PTPI -0.01
- SCNI -0.00
- Stochastic Oscillator
- PTPI 5.23
- SCNI 32.31
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.